With an MC of well over $1B for a company which currently has $0 sales, I can understand why investment advisors rate IMU as speculative. They are simply being cautious. Based on results to date and the imminent announcements on so many trials/applications, the vast majority of IMU holders and posters are extremely confident of brighter future for cancer sufferers and a profitable outcome for holders. The SP is still low which provides an opportunity to accumulate. I would buy more but my better half won't agree, however I'm not selling any until the full potential is realised.
Imugene Price Target Raised 47% to A$0.25/Share by Bell Potter, page-39
-
- There are more pages in this discussion • 172 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $396.8M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 35356 | 8.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 45248 | 1 |
View Market Depth
| Last trade - 09.59am 29/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
Day chart unavailable